FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Stempel

Research Profile

Disorders

Asthma

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Anne Fuhlbrigge; Michael L Reed; David A Stempel; Hector O Ortega; Kristina Fanning; Richard H Stanford
The status of asthma control in the U.S. adult population.
Thomas E Delea; Richard H Stanford; May Hagiwara; David A Stempel
Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.
Michael Lenoir; Cheryl Lynn Walker McGill; Leroy M Graham; Michael Foggs; Sandra Robinson; Courtney Crim; David A Stempel
A new focus on assessing and treating asthma control in the African-American community: a call to action.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Stempel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Anne Fuhlbrigge; Michael L Reed; David A Stempel; Hector O Ortega; Kristina Fanning; Richard H Stanford
The status of asthma control in the U.S. adult population.
Allergy and asthma proceedings : the official journal of regional and state allergy societies 2009;30(5):529-33.
2008: Thomas E Delea; Richard H Stanford; May Hagiwara; David A Stempel
Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.
Current medical research and opinion 2008;24(12):3435-42.
2008: Michael Lenoir; Cheryl Lynn Walker McGill; Leroy M Graham; Michael Foggs; Sandra Robinson; Courtney Crim; David A Stempel
A new focus on assessing and treating asthma control in the African-American community: a call to action.
Journal of the National Medical Association 2008;100(9 Suppl):1-23.
2008: Thomas E Delea; May Hagiwara; Richard H Stanford; David A Stempel
Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
Clinical therapeutics 2008;30(3):560-71.
2007: David A Stempel; Denise T Kruzikas; Ranjani Manjunath
Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
The Journal of pediatrics 2007;150(2):162-7.
2006: David A Stempel; Richard H Stanford; Jacqueline R Carranza Rosenzweig; Trent P McLaughlin
The use of rhinitis medications in children receiving initial controller therapy for asthma.
Current medical research and opinion 2006;22(11):2279-85.
2006: David A Stempel
Assessing the impact of asthma guideline implementation.
Chest 2006;130(1):5-6.
2006: David A Stempel; Joseph D Spahn; Richard H Stanford; Jacqueline R Carranza Rosenzweig; Trent P McLaughlin
The economic impact of children dispensed asthma medications without an asthma diagnosis.
The Journal of pediatrics 2006;148(6):819-23.
2006: David A Stempel; Aylin Altan Riedel; Jacqueline R Carranza Rosenzweig
Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
Current medical research and opinion 2006;22(3):463-70.
2006: Manabu Akazawa; David A Stempel
Single-inhaler combination therapy for asthma: a review of cost effectiveness.
PharmacoEconomics 2006;24(10):971-88.
2006: Michael Lenoir; Alyssa Williamson; Richard H Stanford; David A Stempel
Assessment of asthma control in a general population of asthmatics.
Current medical research and opinion 2006;22(1):17-22.
2005: Richard D O'Connor; Jacqueline R Carranza Rosenzweig; Richard H Stanford; Amanda S Gilmore; Kira L Ryskina; Antonio P Legorreta; David A Stempel
Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2005;95(6):535-40.
2005: David A Stempel; Stuart W Stoloff; Jacqueline R Carranza Rosenzweig; Richard H Stanford; Kira L Ryskina; Antonio P Legorreta
Adherence to asthma controller medication regimens.
Respiratory medicine 2005;99(10):1263-7.
2005: David A Stempel; Trent P McLaughlin; Richard H Stanford
Treatment patterns for pediatric asthma prior to and after emergency department events.
Pediatric pulmonology 2005;40(4):310-5.
2005: B Gwen Carlton; Deborah O Lucas; Elliot F Ellis; Kathleen Conboy-Ellis; Omar Shoheiber; David A Stempel
The status of asthma control and asthma prescribing practices in the United States: results of a large prospective asthma control survey of primary care practices.
The Journal of asthma : official journal of the Association for the Care of Asthma 2005;42(7):529-35.
2005: Trudy B Pendergraft; Richard H Stanford; Richard Beasley; David A Stempel; Trent McLaughlin
Seasonal variation in asthma-related hospital and intensive care unit admissions.
The Journal of asthma : official journal of the Association for the Care of Asthma 2005;42(4):265-71.
2005: David A Stempel; Trent P McLaughin; Richard H Stanford; Anne L Fuhlbrigge
Patterns of asthma control: a 3-year analysis of patient claims.
The Journal of allergy and clinical immunology 2005;115(5):935-9.
2005: David A Stempel; Anne L Fuhlbrigge
Defining the responder in asthma therapy.
The Journal of allergy and clinical immunology 2005;115(3):466-9.
2005: David A Stempel
September epidemic of asthma exacerbations in children: a manifestation of persistent or episodic disease?
The Journal of allergy and clinical immunology 2005;115(2):230-2.
2004: William E Berger; Antonio P Legorreta; Michael S Blaiss; Eric C Schneider; Allan T Luskin; David A Stempel; Samy Suissa; David C Goodman; Stuart W Stoloff; Jean A Chapman; Sean D Sullivan; Bill Vollmer; Kevin B Weiss
The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(6):538-45.
2004: Trudy B Pendergraft; Richard H Stanford; Richard Beasley; David A Stempel; Craig Roberts; Trent McLaughlin
Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;93(1):29-35.
2004: David A Stempel; Craig S Roberts; Richard H Stanford
Treatment patterns in the months prior to and after asthma-related emergency department visit.
Chest 2004;126(1):75-80.
2004: David A Stempel
Exhaled nitric oxide.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2004;92(3):381; author reply 381-2.
2004: Stuart W Stoloff; David A Stempel; Jay Meyer; Richard H Stanford; Jacqueline R Carranza Rosenzweig
Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
The Journal of allergy and clinical immunology 2004;113(2):245-51.
2003: David A Stempel
The pharmacologic management of childhood asthma.
Pediatric clinics of North America 2003;50(3):609-29.
2003: Stuart W Stoloff; David A Stempel
Study design is a major determinant of whether equivalence or superiority is demonstrated.
The Journal of allergy and clinical immunology 2003;111(6):1413; author reply 1413-4.
2003: David A Stempel
Assessing the economic burden of asthma.
The Journal of allergy and clinical immunology 2003;111(6):1203-4.
2002: David A Stempel
The myth of mild asthma.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2002;89(4):340-3.
2002: David A Stempel; Lionel Pinto; Richard H Stanford
The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist.
The Journal of allergy and clinical immunology 2002;110(1):39-41.
2002: David A Stempel; H William Kelly
Approaching value in asthma management: the need to integrate clinical and economic research with the basic science.
The Journal of allergy and clinical immunology 2002;109(5 Suppl):S503-10.
2002: Joseph D Spahn; Ronina A Covar; David A Stempel
Asthma: addressing consistency in results from basic science, clinical trials, and observational experience.
The Journal of allergy and clinical immunology 2002;109(5 Suppl):S490-502.
2002: Homer A Boushey; David A Stempel
Foreword.
The Journal of allergy and clinical immunology 2002;109(5 Suppl):S479-81.
2002: David A Stempel; Roger Woolf
The cost of treating allergic rhinitis.
Current allergy and asthma reports 2002;2(3):223-30.
2002: David A Stempel; John C O'Donnell; Jay W Meyer
Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs.
The Journal of allergy and clinical immunology 2002;109(3):433-9.
2001: David A Stempel; T McLaughlin; D L Griffis; Richard H Stanford
Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up.
Respiratory medicine 2001;95(12):992-8.
2001: David A Stempel; J Mauskopf; T McLaughlin; C Yazdani; Richard H Stanford
Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
Respiratory medicine 2001;95(3):227-34.
2001: David A Stempel; Jay W Meyer; Richard H Stanford; S W Yancey
One-year claims analysis comparing inhaled fluticasone propionate with zafirlukast for the treatment of asthma.
The Journal of allergy and clinical immunology 2001;107(1):94-8.
2000: David A Stempel; Richard H Stanford; RM Thwaites; M J Price
Cost-efficacy comparison of inhaled fluticasone propionate and budesonide in the treatment of asthma.
Clinical therapeutics 2000;22(12):1562-74.
1998: David A Stempel; M Thomas
Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticosteroids versus nonsedating antihistamines.
The American journal of managed care 1998;4(1):89-96.
1997: David A Stempel; A M Carlson; D A Buchner
Asthma: benchmarking for quality improvement.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1997;79(6):517-24.
1997: D A Buchner; A M Carlson; David A Stempel
Patterns of anti-inflammatory therapy in the post-guidelines era: a retrospective claims analysis of managed care members.
The American journal of managed care 1997;3(1):87-93.
1996: David A Stempel; J F Durcannin-Robbins; E C Hedblom; R Woolf; L L Sturm; A B Stempl
Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 1996;76(2):153-8.
1996: David A Stempel; E C Hedblom; J F Durcanin-Robbins; L L Sturm
Use of a pharmacy and medical claims database to document cost centers for 1993 annual asthma expenditures.
Archives of family medicine 1996;5(1):36-40.